Rapport Therapeutics
$25.05
11
+$0.84+3.47%Friday 20:00
+$0.69+2.75%Friday 23:59After hours
Statistics
Day High
25.07
Day Low
24.96
52W High
52.93
52W Low
22.06
Volume
44,408
Avg. Volume
-
Mkt Cap
1.2B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 5Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.2
-0.94
-0.68
-0.42
Expected EPS
-1.203621
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-111.48MNet Income
Analyst Ratings
$66.25Average Price Target
The highest estimate is 89.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RAPP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
Show More
CEO
Abraham N. Ceesay
Employees
84
Country
United States
ISIN
US75383L1026
Listings
0 Comments
Share your thoughts
FAQs
What is Rapport Therapeutics stock price today?▼
The current price of RAPP is $25.05 USD — it has increased by +3.47% in the past 24 hours. Watch Rapport Therapeutics stock price performance more closely on the chart.
What is Rapport Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Rapport Therapeutics stocks are traded under the ticker RAPP.
Is Rapport Therapeutics stock price growing?▼
RAPP stock has fallen by -3.39% compared to the previous week, the month change is a -23.7% fall, over the last year Rapport Therapeutics has showed a -13.41% decrease.
What is Rapport Therapeutics market cap?▼
Today Rapport Therapeutics has the market capitalization of 1.2B
When is the next Rapport Therapeutics earnings date?▼
Rapport Therapeutics is going to release the next earnings report on November 5, 2026.
What were Rapport Therapeutics earnings last quarter?▼
RAPP earnings for the last quarter are -1.19 USD per share, whereas the estimation was -0.96 USD resulting in a -23.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Rapport Therapeutics revenue for the last year?▼
Rapport Therapeutics revenue for the last year amounts to 0 USD.
What is Rapport Therapeutics net income for the last year?▼
RAPP net income for the last year is -111.48M USD.
How many employees does Rapport Therapeutics have?▼
As of November 1, 2026, the company has 84 employees.
In which sector is Rapport Therapeutics located?▼
Rapport Therapeutics operates in the Health & Wellness sector.
When did Rapport Therapeutics complete a stock split?▼
Rapport Therapeutics has not had any recent stock splits.
Where is Rapport Therapeutics headquartered?▼
Rapport Therapeutics is headquartered in BOSTON, United States.